Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Natural History of Treated Neurocysticercosis and Long-Term Outcomes

National Institute of Allergy and Infectious Diseases (NIAID) · NCT00001205

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 3–99 · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
500
US sites recruiting
1
Study start
October 7, 1985
Record last updated
October 13, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Neurocysticercosis is a brain disease due to the larval stage of the pork tapeworm (Taenia solium). The most common symptoms patient experience from infection inside the substance of the brain (parenchymal disease) are seizures and headaches. When the infection is either inside the fluid pockets inside the brain (ventricular disease) or in the space around the brain (subarachnoid disease) patients can have chronic headaches, relapsing aseptic meningitis, hydrocephalus, stroke, and may require neurosurgical intervention. The purpose of this study is to treat patients with anthelmintic therapy (praziquantel and/or albendazole) and anti-inflammatories in alignment with currently accepted best practices and guidelines, depending on the neurocysticercosis subtype. The purpose of the study is to better understand and characterize clinical, biologic, and management factors during treatment that influence long term outcomes. In order to understand this further we collect patient clinical information, patient survey responses, blood, urine samples, and additional cerebral spinal fluid if already being collected for clinical care....

Conditions: Cysticercosis; Neurocysticercosis

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria
  • INCLUSION CRITERIA:

Arms 1-5 (NCC):

  • Aged 3 years and older.
  • Ability of participant (or legally authorized representative, LAR) to understand and the willingness to sign a written informed consent document.
  • Patients with proven or likely NCC

Arm 6 (Endemic Exposures):

  • Patient with epidemiologic history compatible with possible exposure to NCC
  • Aged 18 years and older.

EXCLUSION CRITERIA

Not applicable

Recruiting US locations

  • National Institutes of Health Clinical Center

    Bethesda, MD 20892

Study contacts (from the official record)

  • Perla M Adames Castillo, R.N. · (301) 402-8495 · perla.adamescastillo@nih.gov
  • Elise M O'Connell, M.D. · (301) 761-5413 · oconnellem@mail.nih.gov
All neurology studies in Maryland →
Natural History of Treated Neurocysticercosis and Long-Term Outcomes (NCT00001205) | Bored Studies